Jonathan Leiken - May 12, 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP, CLO and Secretary
Signature
Jonathan B. Leiken
Stock symbol
DBD
Transactions as of
May 12, 2022
Transactions value $
$10,560
Form type
4
Date filed
5/12/2022, 10:32 AM
Previous filing
Mar 10, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Purchase $10.6K +4.4K +1.66% $2.40* 269K May 12, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option 21.4K May 12, 2022 Common Shares 21.4K $32.33 Direct F2
holding DBD Non-Qualified Stock Option 24.6K May 12, 2022 Common Shares 24.6K $27.39 Direct F2
holding DBD Non-Qualified Stock Options 46.9K May 12, 2022 Common Shares 46.9K $26.60 Direct F2
holding DBD Non-Qualified Stock Option 24.5K May 12, 2022 Common Shares 24.5K $18.75 Direct F3
holding DBD Non-Qualified Stock Option 43.7K May 12, 2022 Common Shares 43.7K $4.08 Direct F3
holding DBD Non-Qualified Stock Option 12K May 12, 2022 Common Shares 12K $11.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Number includes restricted stock units.
F2 Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F3 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.